PLDLA/TPU Matrix Enriched with Cyclosporine A as a Therapeutic Platform for Immune-Mediated Keratitis (IMMK) in Horses

The purpose of this study was to describe the use of PLDLA/TPU matrix enriched with cyclosporine A (CsA) as a therapeutic platform in horses with immune-mediated keratitis (IMMK) with an in vitro evaluation CsA release and degradation of the blend as well as determination of the safety and efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Padjasek, Martyna, Cisło-Sankowska, Anna, Lis-Bartos, Anna, Qasem, Badr, Marycz, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057311/
https://www.ncbi.nlm.nih.gov/pubmed/36982806
http://dx.doi.org/10.3390/ijms24065735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057311/
https://www.ncbi.nlm.nih.gov/pubmed/36982806
http://dx.doi.org/10.3390/ijms24065735

Ejemplares similares